Red-Brown Urine Discolouration in Two Patients Taking Mesalamine. - Wikidata - wikimedia - TriplyDB

Red-Brown Urine Discolouration in Two Patients Taking Mesalamine.

Red-Brown Urine Discolouration in Two Patients Taking Mesalamine.

http://www.wikidata.org/entity/Q37219195

about

Red-Brown Urine Discolouration in Two Patients Taking Mesalamine.

http://www.wikidata.org/entity/Q37219195

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on December 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Red-Brown Urine Discolouration in Two Patients Taking Mesalamine.

@en

Red-Brown Urine Discolouration in Two Patients Taking Mesalamine.

@nl

type

label

Red-Brown Urine Discolouration in Two Patients Taking Mesalamine.

@en

Red-Brown Urine Discolouration in Two Patients Taking Mesalamine.

@nl

prefLabel

Red-Brown Urine Discolouration in Two Patients Taking Mesalamine.

@en

Red-Brown Urine Discolouration in Two Patients Taking Mesalamine.

@nl

P1433

Q37219195-CA8ACC61-FBAA-401C-8B8C-8B5C4F33C301

P1476

Q37219195-53FF6BD6-9FEA-462B-BCCB-90123D705FDE

P2093

Q37219195-1A57AEC7-709A-4EF9-A128-6C1BE7F54E1F

Q37219195-C630F7AA-BA60-4EC8-9974-AC26E17504CF

P2860

Q37219195-0B5EA636-6FF8-4F11-86A9-942A798CECE7

Q37219195-2BCE0CBB-A866-4420-9A87-5185B738BA47

Q37219195-567E2A04-B39B-4256-86FC-C6428DFF04F1

Q37219195-680A0F60-BA1D-41FA-910F-E04341E79188

Q37219195-76BC50E5-4EA2-4C16-9973-23DBA527B885

Q37219195-77E3ECEA-76FB-4891-8CBB-6973E062804B

Q37219195-83ACA248-05F6-45FB-B3F2-23B32B21800E

Q37219195-8AC3D507-9EBE-47DB-AB11-DBF62C318619

Q37219195-C9DF3C6B-7239-4C20-8071-BABB3523B1C0

Q37219195-D586895B-F1B0-469B-84ED-2954AF4734FD

P2888

Q37219195-257BC870-FCEE-43EE-9F7B-E2375CB9594B

P304

Q37219195-23889F53-24A0-41E1-94FB-1AEBF961825B

P31

Q37219195-32c9fa5d-47a9-4079-a029-aaa2bbc2b3cd

Q37219195-654FAB16-519E-4E02-B86E-309CDEB66543

P356

Q37219195-BD4BA608-D2B4-4B3A-87E3-49DB37AAF9D3

P433

Q37219195-1D6B224B-BCA2-4780-BD89-7CE6950B4F8F

P478

Q37219195-F560ED6D-4F77-4D7D-8A4D-9BC4FB100EBD

P577

Q37219195-2EC3C933-4DA6-410B-9497-02FFC1474AB5

P698

Q37219195-8BE688D4-4758-4594-9FBC-0D2D706B74BE

P932

Q37219195-4F2AE2A6-3AC2-4296-82AD-172276376741

P356

S40800-016-0029-5

P1433

Drug safety - case reports

P1476

Red-Brown Urine Discolouration in Two Patients Taking Mesalamine.

@en

P2093

Florence van Hunsel

http://www.w3.org/2001/XMLSchema#string

Tim Smeets

http://www.w3.org/2001/XMLSchema#string

P2860

An update of clinical management of acute intermittent porphyria

Systematic review: the pharmacokinetic profiles of oral mesalazine formulations and mesalazine pro-drugs used in the management of ulcerative colitis.

Diagnostic evaluation of rhabdomyolysis.

Melanin synthesis in microorganisms--biotechnological and medical aspects.

5-Aminosalicylates and renal function in inflammatory bowel disease: a systematic review.

Genetic polymorphism in N-Acetyltransferase (NAT): Population distribution of NAT1 and NAT2 activity.

Clinical pharmacology of 5-ASA compounds in inflammatory bowel disease.

Experiences with adverse drug reaction reporting by patients: an 11-country survey.

ADR Reporting by the General Public: Lessons Learnt from the Dutch and Swedish Systems.

P2888

s40800-016-0029-5

P304

6

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40800-016-0029-5

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2016-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27747686

http://www.w3.org/2001/XMLSchema#string

P932

5005790

http://www.w3.org/2001/XMLSchema#string